Researchers at King’s College London have identified a new gene linked to nerve function, which could provide a treatment target for ‘switching off’ the gene in people with neurodegenerative diseases…
Long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson’s disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as Parkinson’s…
The Michael J Fox Foundation has reported today, 1st September 2015, that researchers testing the compound inosine for its effect on Parkinson’s progression have funding from the National Institutes of…
Science Daily reports a new study which claims that low-dose lithium reduced involuntary motor movements or dyskinesia — the troubling side effect of the medication most commonly used to treat…
Science Daily reports that a team led by Fernando Goni, PhD, an adjunct associate professor of Neurology, and Thomas Wisniewski MD, director of the Center for Cognitive Neurology at NYU…
Misfolded protein aggregates represent a continuum with overlapping features in neurodegenerative diseases, but differences in protein components and affected brain regions. The molecular hallmark of synucleinopathies such as Parkinson’s disease,…